← Back to Clinical Trials
Recruiting NCT06621914

NCT06621914 Is Low-load Resistance Training With Blood Flow Restriction Feasible During Rehabilitation of Military Personnel With Lower Limb Injuries? Phase One RCT.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06621914
Status Recruiting
Phase
Sponsor Defence Medical Rehabilitation Centre, UK
Condition Pain
Study Type INTERVENTIONAL
Enrollment 28 participants
Start Date 2024-10-28
Primary Completion 2026-05-29

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
BFR 80BFR40

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 28 participants in total. It began in 2024-10-28 with a primary completion date of 2026-05-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pain can be one of the primary limiting factors to progress following musculoskeletal injury and may be caused by trauma or degenerative changes. There are few exercise rehabilitation interventions able to relieve pain, thereby reducing the number of military personnel fit for operations. Low load blood flow restriction (BFR) exercise has been shown to elicit an analgesic response and promote beneficial physiological changes in a variety of clinical populations. This two phase study, aims to: * Determine the most effective and feasible BFR resistance exercise protocol for reducing pain in UK military patients. * Determine the efficacy of an optimal BFR exercise protocol for reducing pain and improving rehabilitation outcomes in UK military patients. * Identify key physiological mechanisms underpinning any beneficial effect of BFR exercise on pain. Consequently, results from this study will have direct clinical application and will aid best practice guidelines for the management of pain across Defence Rehabilitation by influencing the future rehabilitation paradigm. The investigators believe the results and impact will be far reaching, providing invaluable insight and knowledge to the clinical and scientific community to not only those embedded within Defence Rehabilitation, but also those working in civilian sector organisations and professional sport also.

Eligibility Criteria

Inclusion Criteria: * Serving UK military personnel, * Aged 18-55, * Has unilateral lower limb injury whereby pain is the primary limiting factor hindering progression, as diagnosed by relevant consultant and team, * Reduced occupational employability and function, * Scheduled to attend DMRC Stanford Hall for 3 week residential rehabilitation course. Exclusion Criteria: MSK-Specific Exclusion Criteria * Any medical contraindication related to BFR\* * Non-musculoskeletal or serious pathological condition (i.e. Inflammatory arthropathy, infection or tumour) * Spinal or referred pain from non-local pain source * Any pre-diagnosed physical impairment or co-morbidities (including cardio-vascular disease) precluding the safe participation in the rehabilitation programme and/or assessment procedures * Corticosteroid or analgesic injection intervention to the affected area within the previous 7 days * Currently pregnant, or have not yet completed a return to work assessment following the birth of your child. \*Medical-Related Exclusion Criteria * History of cardiovascular disease (hypertension, peripheral vascular disease, thrombosis/embolism, ischaemic heart disease, myocardial infarction), * History of the following musculoskeletal disorders: rheumatoid arthritis, avascular necrosis or osteonecrosis, severe osteoarthritis * History of the following neurological disorders: Alzheimer's disease, amyotrophic lateral sclerosis, peripheral neuropathy, Parkinson's disease, severe traumatic brain injury, * Varicose veins in the lower limb, * Acute viral or bacterial upper or lower respiratory infection at screening, * Known or suspected lower limb chronic exertional compartment syndrome (CECS) (tourniquet raises intra-compartmental muscle pressure), * Surgical insertion of metal components at the position of cuff inflation, * History of any of the following conditions or disorders not previously listed: diabetes, active cancer, * History of elevated risk of unexplained fainting or dizzy spells during physical activity and/or exercise that causes loss of balance, * Increased risk of haemorrhagic stroke, exercise induced rhabdomyolysis, * Currently pregnant.

Contact & Investigator

Central Contact

Peter Ladlow, PhD

✉ peter.ladlow100@mod.gov.uk

📞 +44 1509 251 500

Principal Investigator

Peter Ladlow, PhD

PRINCIPAL INVESTIGATOR

Defence Medical Rehabilitation Centre, UK

Frequently Asked Questions

Who can join the NCT06621914 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06621914 currently recruiting?

Yes, NCT06621914 is actively recruiting participants. Contact the research team at peter.ladlow100@mod.gov.uk for enrollment information.

Where is the NCT06621914 trial being conducted?

This trial is being conducted at Loughborough, United Kingdom.

Who is sponsoring the NCT06621914 clinical trial?

NCT06621914 is sponsored by Defence Medical Rehabilitation Centre, UK. The principal investigator is Peter Ladlow, PhD at Defence Medical Rehabilitation Centre, UK. The trial plans to enroll 28 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology